A61K 39/098
Brucella
Official title: {Brucella}
A61K39/098 (Brucella) appears on 37 US grants and 54 published applications in this corpus.
Search patents in A61K- Granted patents
- 37
- Published applications
- 54
- Assignees
- 43
- Inventors
- 105
- Latest grant
- 29 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 1 | 2 |
| 2009 | 1 | 1 |
| 2010 | 0 | 4 |
| 2011 | 2 | 4 |
| 2012 | 2 | 5 |
| 2013 | 0 | 1 |
| 2014 | 5 | 7 |
| 2015 | 3 | 3 |
| 2016 | 4 | 4 |
| 2017 | 0 | 2 |
| 2018 | 1 | 1 |
| 2019 | 2 | 2 |
| 2020 | 1 | 2 |
| 2021 | 3 | 3 |
| 2022 | 1 | 2 |
| 2023 | 2 | 1 |
| 2024 | 3 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bioinformatic processes for determination of peptide binding29 Jul 2025US 12,374,421 B2Iogenetics, LLC
- Polysaccharide and methods4 Jun 2024US 11,998,608 B2The Governors of the University of Alberta
- Controlled release vaccines and methods of treating Brucella diseases and disorders7 May 2024US 11,975,060 B2The Texas A&M University System
- Protective immunity enhanced Salmonella vaccine (PIESV) against Brucella spp7 May 2024US 11,975,061 B2University of Florida Research Foundation, Inc.
- Brucella canis vaccine for dogs8 Aug 2023US 11,717,566 B2The Texas A&M University System
- Adjuvant and transmucosal vaccine2 Jul 2026US 2026/0183384 A1Juntendo Educational Foundation
- Bioinformatic processes for determination of peptide binding14 May 2026US 2026/0134941 A1Iogenetics, LLC
- Brucella canis vaccine for dogs13 Feb 2025US 2025/0049907 A1The Texas A&M University System
- Vaccine compositions comprising brucella strains and methods thereof14 Nov 2024US 2024/0374701 A1The Texas A&M University System
- Fusion protein comprising bp26 and antigenic polypeptide17 Aug 2023US 2023/0257426 A1Korea Advanced Institute of Science and Technology
Most cited
By later US patents
- Antigenic polysaccharide specific to Brucella abortus and Yersinia enterocolitica serotype 0:911US 4,831,126 ACanadian Patents and Development Limited · 1989
- Compositions and methods for immunodominant antigens of Mycobacterium tuberculosis10US 7,927,818 B22011
- Bacterial and synthetic polysaccharide immunomodulators that enhance general immunity7US 6,444,210 B1Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence of Her Majesty's Canadian Goverment · 2002
- Brucellosis vaccine for cattle containing mycolate esters of trehalose6US 4,340,588 AResearch Corporation · 1982
- Method for protecting a mammalian host against infection by Brucella6US 6,264,952 B1Board of Supervisors of Louisiana State University and Agricultural and Mechanical College · 2001